The Core Microbiota in a Healthy Population

March 28, 2024

This white paper explores the composition and function of the gut microbiome, its effects on a systemic level, and how advances in microbial profiling are enhancing our understanding of health and disease.



About BIOHIT HealthCare

BIOHIT HealthCare is a Finnish biotech company, headquartered in Helsinki, that specialises in the development, manufacture and distribution of kits and assays for the screening, diagnosis and monitoring of digestive diseases. Its core disease focus areas include stomach health and dyspepsia, reflux and acid dysregulation, Inflammatory Bowel Disease (IBD), functional gastrointestinal disorders (FGID), Irritable bowel syndrome (IBS), and gut microbiota dysbiosis. Innovating for Health www.biohithealthcare.co.uk

Recent Posts

Why proton pump inhibitors aren’t always the answer for silent reflux

November 7, 2024

Is there a link between atrophic gastritis and osteoporosis?

October 15, 2024

Supporting patient wellbeing through remote monitoring of inflammatory bowel disease

September 27, 2024

Exploring advances in TDM for IBD management: insights from our recent webinar

August 21, 2024